Allan E. Rubenstein Sells 6,450 Shares of Cooper Companies Inc (COO) Stock

Cooper Companies Inc (NYSE:COO) Director Allan E. Rubenstein sold 6,450 shares of Cooper Companies stock in a transaction dated Friday, January 12th. The shares were sold at an average price of $228.79, for a total transaction of $1,475,695.50. Following the transaction, the director now directly owns 8,628 shares of the company’s stock, valued at $1,974,000.12. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

Shares of Cooper Companies Inc (COO) opened at $235.19 on Thursday. The firm has a market cap of $11,490.00, a PE ratio of 31.28, a price-to-earnings-growth ratio of 1.87 and a beta of 0.54. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.26 and a current ratio of 2.41. Cooper Companies Inc has a 12 month low of $179.41 and a 12 month high of $256.39.

Cooper Companies (NYSE:COO) last released its quarterly earnings data on Thursday, December 7th. The medical device company reported $2.65 earnings per share for the quarter, beating analysts’ consensus estimates of $2.64 by $0.01. The business had revenue of $561.50 million during the quarter, compared to analyst estimates of $558.86 million. Cooper Companies had a net margin of 17.43% and a return on equity of 16.02%. Cooper Companies’s revenue was up 8.3% compared to the same quarter last year. During the same period last year, the business earned $2.28 EPS. equities research analysts predict that Cooper Companies Inc will post 11.51 earnings per share for the current year.

The company also recently disclosed a semiannual dividend, which will be paid on Friday, February 9th. Shareholders of record on Tuesday, January 23rd will be paid a dividend of $0.03 per share. The ex-dividend date is Monday, January 22nd. This represents a yield of 0.03%. Cooper Companies’s dividend payout ratio is currently 0.80%.

A number of large investors have recently added to or reduced their stakes in the business. Advisory Services Network LLC grew its stake in shares of Cooper Companies by 30.6% in the second quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock worth $109,000 after acquiring an additional 107 shares during the period. YorkBridge Wealth Partners LLC grew its stake in shares of Cooper Companies by 2.1% in the second quarter. YorkBridge Wealth Partners LLC now owns 531 shares of the medical device company’s stock worth $126,000 after acquiring an additional 11 shares during the period. Acrospire Investment Management LLC grew its stake in shares of Cooper Companies by 50.0% in the second quarter. Acrospire Investment Management LLC now owns 600 shares of the medical device company’s stock worth $144,000 after acquiring an additional 200 shares during the period. Canada Pension Plan Investment Board bought a new stake in shares of Cooper Companies in the third quarter worth approximately $163,000. Finally, CAPROCK Group Inc. bought a new stake in shares of Cooper Companies in the fourth quarter worth approximately $222,000. Institutional investors and hedge funds own 96.73% of the company’s stock.

A number of research analysts recently issued reports on the stock. Zacks Investment Research cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Monday, January 8th. Oppenheimer set a $250.00 price target on shares of Cooper Companies and gave the company a “hold” rating in a research report on Friday, December 8th. Stifel Nicolaus reissued a “buy” rating and set a $265.00 price target (down from $275.00) on shares of Cooper Companies in a research report on Friday, December 8th. Raymond James Financial reissued a “buy” rating and set a $265.00 price target on shares of Cooper Companies in a research report on Monday, December 4th. Finally, KeyCorp restated a “hold” rating on shares of Cooper Companies in a research note on Friday, October 20th. Seven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Cooper Companies currently has an average rating of “Buy” and a consensus price target of $259.70.

TRADEMARK VIOLATION NOTICE: This piece of content was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/01/18/allan-e-rubenstein-sells-6450-shares-of-cooper-companies-inc-coo-stock.html.

Cooper Companies Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Insider Buying and Selling by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply